Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.
CSPC Pharmaceutical Group Limited announced the grant of 9,000,000 restricted shares to an employee under its share award scheme. This initiative is designed to recognize the employee’s contributions and incentivize future performance in line with the company’s strategic goals. The shares will vest in four tranches from 2026 to 2029, contingent upon the achievement of specific performance targets. This move aims to retain talent and align employee interests with the company’s growth objectives.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$12.90 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products, with a market emphasis on research and development projects aligned with strategic priorities.
Average Trading Volume: 179,196,349
Technical Sentiment Signal: Buy
Current Market Cap: HK$115.1B
For an in-depth examination of 1093 stock, go to TipRanks’ Overview page.